Dr. Mehmooda Syeed, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1001 Baltimore Pike, Springfield Square South Suite 9b, Springfield, PA 19064 Phone: 484-437-0115 |
News Archive
Controlling HIV/AIDS in India is an "immense" challenge for the country's National AIDS Control Organization - which is preparing to launch on April 1 the third phase of its National AIDS Control Program, a new five-year, $2.6 billion program that aims to reduce the number of new HIV cases and improve access to treatment in the country - NEJM national correspondent Robert Steinbrook writes in a perspective piece.
Metabolic syndrome (MetS) is made up of unhealthy cardiovascular disease (CVD) risk factors including abdominal obesity, high levels of triglycerides, low level of HDL-cholesterol, elevated blood pressure, and elevated fasting glucose level as defined by the American Heart Association/ National Heart, Lung, and Blood Institute (AHA/NHLBI).
In two to five percent of women with breast cancer, tumor cells migrate into the spinal fluid invading the tissue surrounding the brain and spinal cord called the meninges. While a rare complication, the condition is challenging because there is no agreed-upon standard of treatment, leaving little hope for patients affected. Northwestern Medicine- researchers are currently examining a novel approach to delivering an FDA approved drug that they hope will advance research for this type of cancer and lead to discoveries that may improve outcomes in the future.
There are few moments in life as precious, as critical and as celebrated as baby's first breath. New research from the University of Virginia School of Medicine sheds light on the lifelong changes in breathing systems that occur precisely with that first breath – and may offer important insights into Sudden Infant Death Syndrome.
Kineta, Inc. announced today its next generation antiviral program has received a 2.8 million dollar grant from the National Institute of Allergy and Infectious Disease, a part of the National Institutes of Health (NIH). Awarded under the Small Business Innovation Research (SBIR) program, the prestigious phase two grant will provide on-going support for Kineta's work on a new class of antiviral drugs targeting an array of global, deadly viruses.
› Verified 2 days ago